Viva Biotech Holdings

HKEX:1873.HK

0.63 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Operating Activities:
Net Income -117.1261.013-437.274-91.201202.52685.02143.392-530.272219.37646.49639.74450.80622.63819.06519.06519.0656.1186.1186.118
Depreciation & Amortization 100.954110.26293.36792.08779.43873.71648.64221.54420.79313.2515.9083.642.3871.3751.3751.3750.9460.9460.946
Deferred Income Tax 0-143.90430.08463.85166.94480.05821.1167.36611.039-7.88326.19300000000
Stock Based Compensation 7.10411.90315.6259.19210.56110.02311.6872.364.0074.3234.4894.1132.1510000.0040.0040.004
Change In Working Capital -38.668170.17326.392-70.67-38.828-200.518-11.68-14.362-7.641.865-31.7280-5.135-2.483-2.483-2.483-1.99-1.99-1.99
Accounts Receivables -53.03883.47631.113-53.4217.152-105.665-32.94-8.587-11.7153.859-29.10500000000
Change In Inventory 8.51748.525-76.822-19.622-84.65715.5840.137-1.139-3.331-0.299-1.5770-0.394-0.578-0.578-0.578-0.11-0.11-0.11
Change In Accounts Payables 0000000000000000000
Other Working Capital 5.85338.17272.1012.37338.677-110.43721.123-4.6367.406-1.695-1.0460-4.741-1.906-1.906-1.906-1.88-1.88-1.88
Other Non Cash Items 113.69224.098595.324153.209-193.97349.865-169.796541.666-203.099-53.36-15.473-49.389-19.012-10.985-10.985-10.9850.2020.2020.202
Operating Cash Flow 65.956317.449293.43492.61759.72418.10622.24520.93633.43712.5752.949.173.0286.9736.9736.9735.285.285.28
Investing Activities:
Investments In Property Plant And Equipment -86.071-101.607-112.648-136.68-344.739-220.44-543.51-49.114-40.553-15.635-38.79-8.113-11.726-4.731-4.731-4.731-1.835-1.835-1.835
Acquisitions Net 00-81.2020-83.915-126.956-2,453.768-55.805-700000000000
Purchases Of Investments 000000000000-23.725-11.325-11.325-11.325000
Sales Maturities Of Investments 00000000000016.64610.210.210.2000
Other Investing Activites 616.6710.1821.093-43.367411.279-504.064-200.584-546.375-115.825-48.042-34.07711.03118.8045.8565.8565.8561.8351.8351.835
Investing Cash Flow 530.599-91.425-192.757-180.047-17.375-851.46-3,197.862-651.294-226.378-63.677-72.8672.918-18.685-5.796-5.796-5.796-1.683-1.683-1.683
Financing Activities:
Debt Repayment 0-175.620-18.2460-658.690-1,227.1820-3.3950-0.232-0.118-0.112-0.112-0.112-0.106-0.106-0.106
Common Stock Issued 0000000000000000000
Common Stock Repurchased -10.274000-77.285-68.909-52.683-13.581-132.440000000000
Dividends Paid 0000-16.270-51.79200-128.686000000000
Other Financing Activities -559.882-34.966-126.649-34.793216.505-48.514,171.37926.736-26.4911,275.876-2.885182.5960.1180.1120.1120.1120.1060.1060.106
Financing Cash Flow -570.156140.654-126.649-16.547122.95-776.1094,066.9041,240.337-158.9311,143.795-2.885182.364-3.848-0.112-0.112-0.112-0.106-0.106-0.106
Other Information:
Effect Of Forex Changes On Cash -63.6928.366-7.65415.225-33.349-29.992-104.127.2156.6841.0322.641.508-1.1510.0790.0790.079-0.156-0.156-0.156
Net Change In Cash 0395.044-33.626-88.752131.95-1,639.455787.167617.194-345.1881,093.725-70.172195.9631.4474.0854.0854.0850.3530.3530.353
Cash At End Of Period 1,073.6131,073.613678.569712.195800.947668.9972,308.4521,521.285904.0911,249.279155.554225.72638.8897.4427.4427.4423.3563.3563.356